Responses
A difficult case
Amantadine toxicity causing visual hallucinations
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 2 October 2023
- Published on: 2 October 2023Amantadine is a N-metyhl-d-aspartate (NMDA) antagonist.
Amantadine is not a N-metyhl-d-aspartate (NMDA) receptor agonist as stated in the paper, as it's a NMDA antagonist.
References:
- Vanle B, Olcott W, Jimenez J, Bashmi L, Danovitch I, IsHak WW. NMDA antagonists for treating the non-motor symptoms in Parkinson's disease. Transl Psychiatry. 2018 Jun 15;8(1):117. doi: 10.1038/s41398-018-0162-2. PMID: 29907742; PMCID: PMC6003962.,
- Kornhuber J, Weller M, Schoppmeyer K, Riederer P. Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm Suppl. 1994;43:91-104. PMID: 7884411.Note from the editors:
an erratum will be publishedConflict of Interest:
None declared.
Other content recommended for you
- Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis
- Contemporary study of multiple sclerosis disability in South East Wales
- How common is truly benign MS in a UK population?
- Brain atrophy and lesion load predict long term disability in multiple sclerosis
- Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study
- The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry
- Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study
- Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial
- The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)
- UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model